Tag: membrane

Airvine Introduces the “WaveCore™” Flex to Address the “Outside” Backhaul Needs of Enterprise Campus Networks

The Flex complements the original WaveCore, which penetrates thick concrete floors and walls in the interior, to lower the cost of roof-to-indoor, building-to-building and...

Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide

Bergen, Norway, July 23, 2025 – Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO-INN) has approved "getacatetide" as the International Nonproprietary Name (INN) of CY-101.

Telix Reports $204M Revenue, Up 63% YOY

MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise.

Air Products Appoints Matthew Lepore Executive Vice President, General Counsel and Secretary and Chief Compliance Officer

LEHIGH VALLEY, Pa., July 21, 2025 /PRNewswire/ -- Air Products (NYSE:APD) today announced that Matthew Lepore has been appointed Executive Vice President, General Counsel...

Bonatech, a leading Chinese membrane materials company, announces completion of Series A financing

Air Products Declares Quarterly Dividend

LEHIGH VALLEY, Pa., July 18, 2025 /PRNewswire/ -- The Board of Directors of Air Products (NYSE:APD) today declared a quarterly dividend of $1.79 per...

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025

PRESS RELEASE

Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy

REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy

Construct including CT domain demonstrated higher levels of microdystrophin protein, increased muscle force, and improved resistance to damage in mice lacking dystrophin REGENXBIO's next-generation...

Gozellix Receives Permanent HCPCS Code

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA¹ PET² imaging agent, Gozellix® (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection), has been granted a permanent Healthcare Common Procedure Coding System (HCPCS) code by the U.S. Centers for Medicare & Medicaid Services (CMS).

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Lucid Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LCID

Visionary Holdings Inc.Receives Nasdaq Staff Determination Letter and Intends to Request a Hearing

NY Business Leaders Come Out in Force to Support Global Hope & Healing Via the Human-Animal Bond

Airvine Introduces the “WaveCore™” Flex to Address the “Outside” Backhaul Needs of Enterprise Campus Networks

Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide

Telix Reports $204M Revenue, Up 63% YOY

Air Products Appoints Matthew Lepore Executive Vice President, General Counsel and Secretary and Chief Compliance Officer

Bonatech, a leading Chinese membrane materials company, announces completion of Series A financing

Air Products Declares Quarterly Dividend

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025

Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy

REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy

Gozellix Receives Permanent HCPCS Code

Gozellix Receives Permanent HCPCS Code

BioLab Holdings, Inc. Launches Multicenter Clinical Trial to Evaluate Amnion Grafts for Chronic Wounds

Brain Defender Enters 2025 Cognitive Wellness Spotlight as Demand for Transparent, Non-Stimulant Support Surges

Explore

Press Releases

News & Opinion

Living

Others

Follow us